HIGHLIGHTS
- who: Maria A. Papadaki et al. from the Laboratory of Translational Oncology, School of Medicine, University of Crete, Heraklion, Greece have published the research: Investigating the Role of CTCs with Stem/EMT-like Features in Metastatic Breast Cancer Patients Treated with Eribulin Mesylate, in the Journal: Cancers 2022, 14, 3903. of 12/08/2022
- what: This study reveals the prognostic relevance of CTC detection and monitoring in patients with metastatic BC treated with eribulin mesylate. This study reveals for the first time the dynamic alterations in the CSC and EMT status of CTCs early on . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.